Studies have shown that E2A-PBX1 upregulates the expression of BMI-1, while Bmi-1-deficient hematopoietic progenitor cells show resistance to E2A-PBX1-induced tumor metaplasia. This evidence concerns the gene PBX1 and neoplasm.